← Back to patent-cliff list
Govorestat
Tier C — Watch / tradeGovorestat
Applied Therapeutics Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
-
Type
Targets：ALDR1
Indications (approved)：山梨糖醇脱氢酶缺乏症, 夏科-马里-图斯病, 半乳糖激酶缺乏症
Regional status
US
Phase III
2021-03-20
EU
Phase III
2022-01-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Govorestat?
Approved indications include: 山梨糖醇脱氢酶缺乏症, 夏科-马里-图斯病, 半乳糖激酶缺乏症.
When does the Govorestat patent expire?
No public expiry year is available for Govorestat yet; this page updates once verified.
How do I get a quote for Govorestat intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21